Trials / Completed
CompletedNCT03338933
Neurobiology of Alcohol and Nicotine Co-Addiction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 109 (actual)
- Sponsor
- VA Office of Research and Development · Federal
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This proposal addresses the critical absence of information about the neurobiology of recovery from Alcohol Use Disorder (AUD) in alcohol and nicotine users.
Detailed description
This proposal addresses the critical absence of information about the neurobiology of recovery from Alcohol Use Disorder (AUD) in alcohol and nicotine users. AUD and nicotine use disorder (NUD) are the most commonly abused (non-prescription) substances in the U.S. Co-addiction is particularly high in military veterans. Although nationwide estimates peg the rate of AUD/NUD co-addiction at 80%, the Substance Abuse Treatment Program (SATP) at the Veterans Affairs Portland Health Care System (VAPORHCS) finds that 90% of veterans treated for AUD also meet criteria for NUD. The investigators hypothesize that a support vector machine learning algorithm will be able to use the measures to classify subjects as AUD, NUD both or neither and that the algorithm will predict outcome (sobriety or relapse) at three months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | magnetic resonance imaging (MRI) | All subjects will undergo a baseline MRI and subjects in both alcohol groups (alcohol use disorder and combined alcohol and nicotine use disorder) will undergo a followup MRI 3 months after baseline. |
Timeline
- Start date
- 2018-02-08
- Primary completion
- 2023-01-03
- Completion
- 2023-01-03
- First posted
- 2017-11-09
- Last updated
- 2025-02-13
- Results posted
- 2025-02-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03338933. Inclusion in this directory is not an endorsement.